Cargando…

Ga-68-Edotreotide Positron Emission Tomography/Computed Tomography Somatostatin Receptors Tumor Volume Predicts Outcome in Patients With Primary Gastroenteropancreatic Neuroendocrine Tumors

BACKGROUND: We retrospectively aimed to assess the prognostic significance of somatostatin receptor (SSTR) standardized uptake value (SUVmax(sstr)), SSTR representative tumor volume (RTV(sstr)) and total lesion SSTR expression (TL(sstr)) obtained by [(68)Ga]Ga-edotreotide PET/CT ([(68)Ga]Ga-SSTR PET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gallicchio, Rosj, Giordano, Alessia, Milella, Mariarita, Storto, Rebecca, Pellegrino, Teresa, Nardelli, Anna, Nappi, Antonio, Tarricone, Luigia, Storto, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940184/ https://www.ncbi.nlm.nih.gov/pubmed/36714951 http://dx.doi.org/10.1177/10732748231152328

Ejemplares similares

Combined bone scintigraphy and fluorocholine PET/computed tomography predicts response to radium-223 therapy in patients with prostate cancer
por: Klain, Michele, et al.
Publicado: (2021)

Coexisting Somatostatin Receptor Expressing Gastric Neuroendocrine Tumor Primary and Lymph Nodal Tuberculosis on (68)Ga-DOTANOC Positron Emission Tomography/Computed Tomography
por: Arora, Saurabh, et al.
Publicado: (2020)

[F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients
por: Nappi, Antonio, et al.
Publicado: (2015)

Pain predicts overall survival in men with metastatic castration-resistant prostate cancer treated with radium-223
por: Roviello, Giandomenico, et al.
Publicado: (2018)

Inflammatory Myofibroblastic Tumor: Findings on (68)Ga-DOTA-NOC Positron-emission Tomography-Computed Tomography
por: Tripathy, Sarthak, et al.
Publicado: (2020)

(68)Ga-DOTATATE positron emission tomography/computed tomography scan in the detection of bone metastases in pediatric neuroendocrine tumors
por: Goel, Reema, et al.
Publicado: (2014)

(68)Ga-DOTATATE positron emission tomography/computed tomography to detect the recurrence of phosphaturic mesenhcymal tumor-induced osteomalacia
por: Bhalla, Manav I., et al.
Publicado: (2019)

Graves' Ophthalmopathy on (68)Ga-DOTANOC Positron Emission Tomography/Computed Tomography
por: Arora, Saurabh, et al.
Publicado: (2019)

An Incidental Solitary Plasmacytoma of Bone Mimicking Neuroendocrine Tumor Metastasis on 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography
por: Şimşek, Duygu Has, et al.
Publicado: (2016)

Ectopic Parathyroid Adenoma Mimicking as a Neuroendocrine Tumor on Ga68- DOTANOC Positron Emission Tomography/Computed Tomography Imaging
por: Subramanian, Karthikeyan, et al.
Publicado: (2021)

Incidental Meningioma on (68)Ga-DOTANOC Positron-Emission Tomography
por: Parihar, Ashwin Singh, et al.
Publicado: (2018)

The predictive impact of dual somatostatin receptor/fluorodeoxyglucose (FDG) positron emission tomography (PET) in metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs): review of literature and a single institution experience
por: Mohamed, Amr, et al.
Publicado: (2023)

Current knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUV(max) reference range for management of pancreatic neuroendocrine tumours
por: Virgolini, Irene, et al.
Publicado: (2016)

Diffuse nesidioblastosis diagnosed on a Ga-68 DOTATATE positron emission tomography/computerized tomography
por: Arun, Sasikumar, et al.
Publicado: (2013)

Ga-68 DOTATATE Positron Emission Tomography/Computed Tomography in a Rare Case of Esthesioneuroblastoma
por: Verma, Priyanka, et al.
Publicado: (2021)

(68)Ga-DOTATATE-positron emission tomography imaging in spinal meningioma
por: Slotty, Philipp Jörg, et al.
Publicado: (2014)

Spinal molecular imaging by (68) Ga-DOTATATE-positron emission tomography
por: Sandu, Nora, et al.
Publicado: (2014)

(68)Ga-bisphosphonates for the imaging of extraosseous calcification by positron emission tomography
por: Keeling, George P., et al.
Publicado: (2023)

Current status and future of targeted peptide receptor radionuclide positron emission tomography imaging and therapy of gastroenteropancreatic-neuroendocrine tumors
por: Grey, Neil, et al.
Publicado: (2022)

Correlation between Standardized Uptake Value of (68)Ga-DOTA-NOC Positron Emission Tomography/Computed Tomography and Pathological Classification of Neuroendocrine Tumors
por: Kaewput, Chalermrat, et al.
Publicado: (2018)

Prospective Analysis of the Impact of (68)Ga-DOTATOC Positron Emission Tomography–Computerized Axial Tomography on Management of Pancreatic and Small Bowel Neuroendocrine Tumors
por: Ghobrial, Silvia N., et al.
Publicado: (2020)

GMP-compliant production of [(68)Ga]Ga-NeoB for positron emission tomography imaging of patients with gastrointestinal stromal tumor
por: Pretze, Marc, et al.
Publicado: (2021)

Somatostatin Analogs Therapy in Gastroenteropancreatic Neuroendocrine Tumors: Current Aspects and New Perspectives
por: Baldelli, Roberto, et al.
Publicado: (2014)

Insulinoma - The incremental value of somatostatin receptor positron emission tomography
por: Arunraj, S. T., et al.
Publicado: (2017)

Hypoglycemia-Triggered Motion Artifact on (68)Ga-DOTA-TOC Positron Emission Tomography/Computed Tomography
por: Chandra, Piyush, et al.
Publicado: (2021)

Prognostic Value of Hybrid PET/MR Imaging in Patients with Differentiated Thyroid Cancer
por: Piscopo, Leandra, et al.
Publicado: (2022)

Additional information gained by positron emission tomography with (68)Ga-DOTATOC for suspected unknown primary or recurrent neuroendocrine tumors
por: Nakamoto, Yuji, et al.
Publicado: (2015)

Carbon Nanomaterials for Sorption of (68)Ga for Potential Using in Positron Emission Tomography
por: Kazakov, Andrey G., et al.
Publicado: (2020)

Corticomedullary Mixed Tumor of the Adrenal Gland with Apparent (18)F-Fluorodeoxyglucose Activity But No (68)GA-DOTATATE Uptake on Positron Emission Tomography/Computed Tomography
por: Engur, Ceren Ozge, et al.
Publicado: (2022)

Highly variable biodistribution of (68)Ga labeled somatostatin analogues (68)Ga-DOTA-NOC and (68)Ga-DOTA-TATE in neuroendocrine tumors: clinical implications for somatostatin receptor directed PET/CT
por: Cheng, Monica, et al.
Publicado: (2022)

Breast Metastasis Detected on Ga-68 DOTATATE Positron Emission Tomography/Computed Tomography Imaging in Malignant Pheochromocytoma
por: Parghane, Rahul Vithalrao, et al.
Publicado: (2015)

(68)Ga-Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography: How Much Specific It Is?
por: Sahoo, Manas Kumar
Publicado: (2017)

Incidental Detection of Asymptomatic Brain Metastases on (18)F-fluoride Positron Emission Tomography/Computed Tomography and (68)Ga DOTANOC Positron Emission Tomography/Computed Tomography in a Patient with Concomitant Breast Carcinoma and a Pancreatic Neuroendocrine Tumor
por: Brown, Ruth, et al.
Publicado: (2018)

Clinical Significance of Protein Expression of Cyclooxygenase-2 and Somatostatin Receptors in Gastroenteropancreatic Neuroendocrine Tumors
por: Kim, Hee Sung, et al.
Publicado: (2011)

Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitals
por: Ortendahl, Jesse D, et al.
Publicado: (2017)

Dynamic (68)Ga-DOTA(0)-Tyr(3)-octreotate positron emission tomography-computed tomography for the evaluation of pancreatic neuroendocrine tumors: a pilot study
por: Yin, Hongyan, et al.
Publicado: (2023)

The Synthesis and Evaluations of the (68)Ga-Lissamine Rhodamine B (LRB) as a New Radiotracer for Imaging Tumors by Positron Emission Tomography
por: Li, Xuena, et al.
Publicado: (2016)

Imaging of Pseudomonas aeruginosa infection with Ga-68 labelled pyoverdine for positron emission tomography
por: Petrik, Milos, et al.
Publicado: (2018)

Therapeutic Strategies in HCC: Radiation Modalities
por: Gallicchio, R., et al.
Publicado: (2016)

Patient And Nurse Experience Of Using Somatostatin Analogues To Treat Gastroenteropancreatic Neuroendocrine Tumors: Results Of The Somatostatin Treatment Experience Trial (STREET)
por: Ström, Torbjörn, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e5p885p8bsu227824hvn740gg1